| Paul J Hamori, MD | |
|
10801 N Michigan Rd Ste 205, Zionsville, IN 46077-8171 | |
| (317) 733-1829 | |
| Not Available |
| Full Name | Paul J Hamori |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 10801 N Michigan Rd Ste 205, Zionsville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265408801 | NPI | - | NPPES |
| 200008530 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 01038454A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascenson At Home | Indianapolis, IN | Home health agency |
| Ascension St Vincent Hospital | Indianapolis, IN | Hospital |
| Ascension St Vincent Carmel | Carmel, IN | Hospital |
| Ascension St Vincent Fishers | Fishers, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Vincent Medical Group Inc | 7012047640 | 625 |
News Archive
Among patients with relapsing-remitting multiple sclerosis (MS), treatment with the widely-prescribed drug to treat MS, interferon beta, was not associated with less progression of disability, according to a study in the July 18 issue of JAMA.
Commenting on Edward Boyden's article, Ben Barres, Head of the Neuronal & Glial Cell Biology Section of Faculty of 1000 and Professor at Stanford University School of Medicine said: "There will probably be a Nobel prize for optogenetics someday as it has revolutionized our attempts to understand how the brain works. This article provides a fascinating insight into the birth of optogenetics and the roles of the major players."
Scientists in the U.S. say a significant number of premature births may be caused by infections which are undiagnosed and the heavier the infection, the more likely the women were to deliver younger, sicker babies.
Alzheimer's disease and related dementias are projected to increase more than six-fold among Hispanics in the U.S. during the first half of the 21st century, according to a new report released today by the Alzheimer's Association. This increase means that 1.3 million Hispanics will have Alzheimer's disease by 2050, compared to fewer than 200,000 currently living with the disease.
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
› Verified 7 days ago
| Entity Name | St Vincent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144513375 PECOS PAC ID: 7012047640 Enrollment ID: O20100609000045 |
News Archive
Among patients with relapsing-remitting multiple sclerosis (MS), treatment with the widely-prescribed drug to treat MS, interferon beta, was not associated with less progression of disability, according to a study in the July 18 issue of JAMA.
Commenting on Edward Boyden's article, Ben Barres, Head of the Neuronal & Glial Cell Biology Section of Faculty of 1000 and Professor at Stanford University School of Medicine said: "There will probably be a Nobel prize for optogenetics someday as it has revolutionized our attempts to understand how the brain works. This article provides a fascinating insight into the birth of optogenetics and the roles of the major players."
Scientists in the U.S. say a significant number of premature births may be caused by infections which are undiagnosed and the heavier the infection, the more likely the women were to deliver younger, sicker babies.
Alzheimer's disease and related dementias are projected to increase more than six-fold among Hispanics in the U.S. during the first half of the 21st century, according to a new report released today by the Alzheimer's Association. This increase means that 1.3 million Hispanics will have Alzheimer's disease by 2050, compared to fewer than 200,000 currently living with the disease.
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul J Hamori, MD 10801 N Michigan Rd Ste 205, Zionsville, IN 46077-8171 Ph: () - | Paul J Hamori, MD 10801 N Michigan Rd Ste 205, Zionsville, IN 46077-8171 Ph: (317) 733-1829 |
News Archive
Among patients with relapsing-remitting multiple sclerosis (MS), treatment with the widely-prescribed drug to treat MS, interferon beta, was not associated with less progression of disability, according to a study in the July 18 issue of JAMA.
Commenting on Edward Boyden's article, Ben Barres, Head of the Neuronal & Glial Cell Biology Section of Faculty of 1000 and Professor at Stanford University School of Medicine said: "There will probably be a Nobel prize for optogenetics someday as it has revolutionized our attempts to understand how the brain works. This article provides a fascinating insight into the birth of optogenetics and the roles of the major players."
Scientists in the U.S. say a significant number of premature births may be caused by infections which are undiagnosed and the heavier the infection, the more likely the women were to deliver younger, sicker babies.
Alzheimer's disease and related dementias are projected to increase more than six-fold among Hispanics in the U.S. during the first half of the 21st century, according to a new report released today by the Alzheimer's Association. This increase means that 1.3 million Hispanics will have Alzheimer's disease by 2050, compared to fewer than 200,000 currently living with the disease.
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
› Verified 7 days ago
Dr. Timothy Raymond Franson, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 11610 Weeping Willow Ct, Zionsville, IN 46077 Phone: 317-840-4600 | |
Dr. Alan E Handt, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 705 Pineview Dr, Zionsville, IN 46077 Phone: 317-873-5922 | |
Dr. Maria Rivas, MD, FACP, FACE Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4631 Hickory Ct, Zionsville, IN 46077 Phone: 317-873-5012 | |
Dr. Kimberly Rose Gatzimos, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1650 W Oak St Ste 203, Zionsville, IN 46077 Phone: 317-873-1200 Fax: 317-873-1209 | |
Belinda J Watts, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 W Oak St, Ste 104, Zionsville, IN 46077 Phone: 317-873-8910 Fax: 317-873-8821 | |
Dr. Charles Thomas Benson, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6733 Beekman Pl W, Zionsville, IN 46077 Phone: 317-769-7770 |